Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
A Standard patent application filed on 01 May 1997 credited to Jirousek, Michael R.
;
Ways, Douglas Kirk
;
Stramm, Lawrence E.
Details
Application number :
30002
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
Inventor :
Jirousek, Michael R.
;
Ways, Douglas Kirk
;
Stramm, Lawrence E.
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
01 May 1997
Associated companies :
Applicant name :
Eli Lilly and Company
Applicant address :
Lilly Corporate Center Indianapolis Indiana 46285 United States Of America